PR95465 

European Wellness Signs MOU in Dubai Expo 2020 to Strengthen Medical Tourism into Malaysia and Develop Advanced Biological Regenerative Medicine in UAE 

DUBAI, UAE, April 13, 2022 /PRNewswire=KYODO JBN/ --

European Wellness Biomedical Group (EW Group), through its Malaysian subsidiary

European Wellness Academie, and Dubai- based healthcare distribution and

technology group, AK International LLC, have signed a Memorandum of

Understanding (MOU) on 30th March 2022 that aims to strengthen the medical

tourism linkages and access to Biological Regenerative Medicine services in the

United Arab Emirates and Malaysia.

The signing marks a significant milestone in EW Group's effort to scale up the

global adoption of rapidly emerging German and Swiss medical paradigms and

cell-based bio- therapeutics for the integrative management of chronic

degenerative conditions and untreatable rare diseases.

Witnessed by YAB Dato' Sri Ismail Sabri Yaakob, Prime Minister of Malaysia, the

MOU were signed by Prof. Dato' Sri Dr. Mike Chan, European Wellness Group

Chairman and Dr. Aasif Ali Siddiqui, Managing Director of AK International.

The strategic collaborations seeks to setup two Centers of Excellence, one

specializing in the rehabilitation, education and holistic management of

pediatric neurodegenerative and neurodevelopmental disorders such as Autism

Spectrum Disorder, Cerebral Palsy, Down Syndrome and Global Developmental

Delay, and another specializing in the management of untreatable and rare

diseases such as CHARGE Syndrome, Multiple Sclerosis, Rheumatoid Arthritis,

Parkinson's Disease etc.

EW Group Chairman Prof. Dato' Sri Dr. Mike said, "We are confident that our 30

years of cell therapeutic research efforts across Europe, along with a

passionate team of international top clinicians trained in Germany and

Switzerland, can support the delivery of an impactful and personalized disease

management model to the communities in UAE."

"Moreover, these Centers are also vital frontlines to assist local patients

seeking for biological regenerative medicine solutions at our overseas

destinations to have easy access to an efficient and collaborative case

referral network – from initial inquiry, to preliminary medical investigation,

to assisted medical travel, and finally to follow-up care," he said.

Since 2017, EW Group has embraced the growth strategies of licensing its

proprietary clinical systems, protocols and patented bio-therapeutics to new

joint-ventures, rendering the rapid expansion of its healthcare facility

division from 2 flagship centers in Switzerland and Malaysia in 2016 to a

global network of 26 medical and healthcare centers today.

In addition, EW Group and AK International are looking into the development of

a technology driven 'Digital Wellness Service Corridor', in the form of an

AI-driven application pioneered by AK International's subsidiary Artelir Inc.

that shall seamlessly connect patients from United Arab Emirates with

healthcare service providers in Malaysia.

AK International Director Dr. Aasif Ali Siddiqui commented, "One of the goals

of this MOU is to increase medical and wellness tourism in Malaysia while also

offering Emiratis modern medical treatments in other countries. Patients with

incurable uncommon diseases or neurodegenerative disorders, for example, may

have restricted access to innovative treatment alternatives, such as cell-based

or biomolecular therapies, in their local area."

The partnership is also set to explore potential investments into Iskandar

Malaysia Development Area in Johor for the development of a world-leading Halal

Hub for Biotechnology and Regenerative Medicine. The unique development project

valued at USD 60million shall comprise a 100-bed integrative medicine hospital

modelled after EW Group's medical facility in Germany, Muslim-centered aged

care retirement villas and assisted living apartments, and a GMP-certified

halal biologics and botanical drug manufacturing facility.

"Our Group is ever ready to extend more than 50 of our proprietary plant-based

pharmaceuticals with German approval for immediate production in Malaysia and

export to meet the growing global demand for natural medicine," Dato' Sri Mike

said.

"This project will bring a tremendous opportunity to strengthen Malaysia's

vision and current positioning as the world's Muslim hub for innovative

biotechnology developments, especially on herbal medicine research and

botanical drug manufacturing."

EW Group is a recipient of multiple awards for its pioneering biotech

innovations in Paris, Geneva, London and Kuwait, and currently holds multiple

international patents on innovative biotechnological processes and formulation

for its Cell and Gene Therapy Products (CGTP) and Biologics, including

precursor (progenitor) stem cells, biological peptides and anti-idiotypic

antiobodies for immunology and botanical formulation for parenteral nutrition.  

About European Wellness Biomedical Group

European Wellness Biomedical Group (EW Group) is an award-winning European

group founded by Prof. Dato' Sri Dr. Mike Chan and Prof. Dato' Sri Dr. Michelle

Wong in early '90s in Switzerland through the culmination of early cell

therapeutic research efforts spanning across Switzerland, Germany, Russia and

Austria since the mid '80s.

Today, EW Group is most renowned for its pioneering developments in

organ-specific precursor (progenitor) stem cell therapeutics, biological and

synthetic peptides, biological regenerative medicine, immunotherapies,

nutraceuticals and cosmeceuticals. EW Group's multinational business divisions

include research and development; bio-manufacturing; biomedical academies for

continuing education and training (including 20+ published medical books, 50+

scientific journals and 20+ international accreditations); medical facilities

and anti-ageing centres; and nutraceutical product distribution to licensed

practitioners and consumers across 80 countries worldwide.

EW Group also owns and operates a growing network of internationally accredited

Hospital and Medical Centers specialising in Regenerative Biomedicine and

luxury Wellness Centres globally. Currently, the Group is headquartered in

Germany and Malaysia (Asia Pacific) with its own research and biopharmaceutical

manufacturing facilities vested in Germany, Switzerland, United States, Czech

Republic, and United Kingdom.

https://european-wellness.eu

SOURCE-European Wellness Biomedical Group

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=419100

   Caption: EW Group and AK International's MOU signing was the first to be finalised

during the signing ceremony, under the witness of Malaysia’s Prime Minister YAB

Datuk Seri Ismail Sabri Yaakob, Science, Technology and Innovation Minister

Datuk Seri Dr Adham Baba, International Trade and Industry Minister Datuk Seri

Mohamed Azmin Ali, Rural Development Minister Datuk Seri Mahdzir Khalid, and

Deputy Minister of Works Datuk Arthur Joseph Kurup.